Every year, thousands of the world’s leading cancer researchers convene to share the latest scientific advances and clinical research discoveries at the annual meeting of the American Association for Cancer Research. he Luminex team was excited to attend another insightful AACR annual meeting.
Inspired by the inventive ways our Luminex Partners benefit healthcare, we spotlight one of our newest Partners, ImmunoProfile®. Founded by two veterans in the medical devices industry, ImmunoProfile® offers an IgG serology test panel to easily learn your antibody protection level to each of 11 different infectious diseases.
The Luminex team was pleased to attend this year’s World Vaccine Congress, which took place in April in Washington, DC. With so much innovation in vaccine development and commercialization occurring globally, it was exciting to learn about the latest advancements from some of the field’s leaders.
Grifols Laboratory Solutions is transforming blood transfusions with its genotyping test, BGG Navigator, using xMAP® Technology. This 37-plex antigen test provides comprehensive blood typing, enabling higher quality matches between donors and recipients. Learn more about how Grifols is improving transfusion medicine on their website.
Attendees of our latest xMAP® Connect event learned about the impact of multiplex testing for patients with vascular brain injury from Jason Hinman: Associate Professor at the University of California, Los Angeles and President of Sage Cerebrovascular Diagnostics.
Researchers at Rush University Medical Center has created a helpful video tutorial for anyone interested in monitoring the immune response to a COVID-19 vaccine or SARS-CoV-2 infection. The team’s method demonstrates how to measure dynamic antibody titer changes in IgA, IgM, or IgG.
Scientists working in drug discovery and biologics development were treated to an informative and insightful PepTalk 2023 conference in San Diego, CA. Participants from top global pharma, biotech, academic, and governmental institutions convened to learn about the latest scientific advancements in cutting-edge biologic therapies.
We always look forward to xMAP Connect user group meetings—not only do they give scientists a chance to share their experiences with xMAP® Technology, but they offer deep dives into the amazing research enabled by our multiplexing platform.
Prime Diagnostics, Wageningen University’s team of scientific experts develops, validates, and commercializes testing kits to identify pathogens in economically important plants such as crops and garden flowers.
There aren’t many high-throughput life science technologies that have as long a track record as our multiplexing xMAP® Technology for proteomic and genomic assays. In fact, there have now been more than 60,000 peer-reviewed papers citing xMAP Technology and our partners’ xMAP-based products.